NCT02215733View on ClinicalTrials.gov

The Use of Angiotensin Receptor Blockers and the Risk of Cancer

CompletedOBSERVATIONAL
Enrollment

1,165,781

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

February 29, 2012

Conditions
Neoplasm
Interventions
DRUG

ARB

other than telmisartan

DRUG

ACEI

DRUG

Beta-blockers

DRUG

Diuretics

DRUG

Telmisartan

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY